Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonyms
CD152, Cytotoxic T-lymphocyte protein 4, Cytotoxic T-lymphocyte-associated antigen 4
SDS-PAGE analysis of Ipilimumab Biosimilar - Anti-CTLA4 Antibody - Low endotoxin, Azide free (A323516) under reducing (R) conditions confirms that the purity of this antibody is greater than 95%.
SEC-HPLC analysis of Ipilimumab Biosimilar - Anti-CTLA4 Antibody - Low endotoxin, Azide free (A323516) confirms that the purity of this antibody is 99.37%.
Human CTLA-4 & Human PD-1 CHO-K cells were stained with Ipilimumab Biosimilar - Anti-CTLA4 Antibody - Low endotoxin, Azide free (A323516) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC50 = 0.2270 µg/ml.
Ipilimumab Biosimilar - Anti-CTLA4 Antibody - Low endotoxin, Azide free (A323516) inhibited the tumor growth of MC38 on huCTLA-4 mice. The result showed significant anti-tumor effects, with an tumor inhibition rate (TGI) of 99.3% at 0.88 mpk at D37.
Publishing research using Ipilimumab Biosimilar - Anti-CTLA4 Antibody - Low endotoxin, Azide free (A323516)? Please let us know so that we can list the citation on this page.
Alternative products to Ipilimumab Biosimilar - Anti-CTLA4 Antibody - Low endotoxin, Azide free (A323516)